SCHEMBL1680408

SCHEMBL1680408

CCCOCCc1ccc(Br)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.45
HTR2A P28223 1/20 0.45
POLB P06746 2/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
MAPK1 P28482 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
CYP3A4 P08684 1/20 0.39
CASP1 P29466 1/20 0.39
KMT2A Q03164 1/20 0.39
SLCO1B3 Q9NPD5 1/20 0.39
SLCO1B1 Q9Y6L6 1/20 0.39
IDO1 P14902 2/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2515837 0.89 TAAR1 (0.54) TAAR1HTR2APOLBCTDSP1IDO1
SCHEMBL11104424 0.88 MAPK1 (0.47) TAAR1HTR2APOLBCTDSP1MAPK1
SCHEMBL11108664 0.85 TAAR1 (0.47) TAAR1HTR2APOLBCTDSP1ALDH1A1
SCHEMBL18857101 0.85 TAAR1 (0.46) TAAR1MAPK1SMN1; SMN2LMNAALDH1A1
SCHEMBL8417751 0.83 TAAR1 (0.45) TAAR1HTR2APOLBCTDSP1SMN1; SMN2
SCHEMBL8418497 0.81 IDO1 (0.50) TAAR1HTR2APOLBCTDSP1LMNA
SCHEMBL6229666 0.81 CA1 (0.42) TAAR1LMNAALDH1A1CASP1IDO1
SCHEMBL12299452 0.81 KCNH2 (0.53) TAAR1IDO1CYP1A2KCNH2
SCHEMBL6123807 0.80 TAAR1 (0.52) TAAR1MAPK1SMN1; SMN2LMNAALDH1A1
SCHEMBL7931860 0.80 TAAR1 (0.42) TAAR1HTR2APOLBCTDSP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111362833-A Dianthracene D-delta-A type deep blue organic fluorescent material and preparation method and application thereof 陕西师范大学 2020-07-03 CN claimed
CN-111362833-B Double anthracene D-delta-A type deep blue organic fluorescent material and preparation method and application thereof 陕西师范大学 2023-04-25 CN disclosed
CN-111362833-A Dianthracene D-delta-A type deep blue organic fluorescent material and preparation method and application thereof 陕西师范大学 2020-07-03 CN disclosed
EP-1943239-B1 PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS BASF SE (DE) 2011-11-09 EP disclosed
EP-1943239-B1 PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS BASF SE (DE) 2011-11-09 EP disclosed
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-20070078267-A1 Organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 US disclosed
US-20070078267-A1 Organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 US disclosed
US-20070078267-A1 Organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 US disclosed
US-20070077681-A1 Liquid phase fabrication of active devices including organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 US disclosed
US-20070077681-A1 Liquid phase fabrication of active devices including organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 US disclosed
US-20070075630-A1 Organic compositions BASF AKTIENGESELLSCHAFT (DE) 2007-04-05 US disclosed
US-20070075630-A1 Organic compositions BASF AKTIENGESELLSCHAFT (DE) 2007-04-05 US disclosed
US-20070075630-A1 Organic compositions BASF AKTIENGESELLSCHAFT (DE) 2007-04-05 US disclosed
EP-1669348-A1 NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 2006-06-14 EP disclosed
US-4431564-A 4'-/2-ALKYLOXYETHYL/-4-CYANOBI-OR TERPHENYLS; DISPLAYING; IODINATION AND CYANATION THE ESTER DERIVATIVE CHISSO CORPORATION (JP) 1984-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND ERG28, CYP51A1, XPO1 TAAR1 2049/4885HTR2A 3780/4885POLB 4378/4885
US-20070078267-A1 Organic semiconductors ORC3, C1S, C5 TAAR1 470/4885HTR2A 1473/4885POLB 494/4885
US-20070075630-A1 Organic compositions BPNT1, RFT1, FERMT2 TAAR1 2677/4885HTR2A 3180/4885POLB 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.